Through functional approaches in in vitro and in vivo models it has been demonstrated that RPN11/PSMD14 supports tumor aggressive features through a mechanism that involves Leucine Rich Pentatricopeptide Repeat Containing (LRPPRC). This evidence concerns the gene PSMD14 and neoplasm.